Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.

Yajuan CaoWeikang ZhuWanqing ChenJianchun WuGuozhen Hou Yan Li

Published in: Disease markers (2019)

Overexpressed in tumors, BIRC5 is associated with unfavorable overall survival in TN adenocarcinomas. BIRC5 is a potential predictor and therapeutic target in TN adenocarcinomas.

Keyphrases

bioinformatics analysis
small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
squamous cell
free survival
human health
risk assessment